These risks appear to be present regardless of a person's age or health at the time of infection.

These elevated risks extend well beyond the initial infection period, researchers caution.

These findings are not exclusive to severe cases of the virus and have been observed in individuals who reported having more moderate infections.

Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus. 

Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.